The Role of Neonatal Fc Receptor (FcRn) Blocking Therapeutics in the Management of Patients with Generalized Myasthenia Gravis

Nov 7, 2022

- Nov 6, 2023

0.75

Claim your AMA PRA Category 1 Credit(s)

This course is available for logged in users only. Please login or register to take the course.

Clinical Update on Non-Cystic Fibrosis Bronchiectasis (NCFBE): Diagnostics, Pathophysiolog...

The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Pati...

ATTRv-PN: Advances in Understanding and Managing Amyloid Disease with Peripheral Neuropath...